芬太尼反弹是纳洛反弹的内在特征吗?
Michael Voronkov1, Georgiy Nikonov2, Melda Uzbil1
1Serodopa Therapeutics Inc., Gainesville, FL 32601, USA.
Pharmaceuticals (Basel, Switzerland)
|November 27, 2025
概括
较高剂量的纳洛 (NX) 对于逆转芬太尼过量服用,比长效的抗药更有效. 这是因为纳洛暴露,而不是其半衰期,延迟了芬太尼的再麻醉,并降低了戒断风险.
科学领域:
- 药理学 药理学是指药理学的学科.
- 毒理学 毒理学 毒理学
- 药物开发 药物开发
背景情况:
- 芬太尼驱动着阿片类药物流行,需要有效的逆转药物.
- 纳洛 (NX) 是一种常见的解毒剂,但由于半衰期不匹配,因芬太尼重新麻醉而面临挑战.
- 更长效的抗毒剂是另一种选择,但纳洛的戒断责任较低.
研究的目的:
- 为了比较纳洛 (NX) 和其前药物 (NX90) 与芬太尼的药理动力学 (PK) 概况.
- 评估NX和NX90在预防芬太尼重新麻醉中的有效性.
- 评估纳洛暴露和芬太尼 PK 参数之间的关系.
主要方法:
- 在接受芬太尼镇静剂的狗身上进行了一项药理动力学交叉研究.
- 纳洛 (NX) 和其脂友性前药物 (NX90) 被给予并与安慰剂进行比较.
- 分析了芬太尼和纳洛的血水平,以确定PK概况和再麻醉风险.
主要成果:
- 纳洛的使用将芬太尼重新分配到血中,与纳洛水平相关 (R2 = 0.9121).
- 这种重新分配减少了芬太尼的分布量,平均停留时间和半衰期.
- 重新麻醉的延迟与纳洛暴露相关 (AUCinf,R2 = 0.794),独立于纳洛的半衰期.
结论:
- 芬太尼的再分配和延迟的再麻醉与纳洛暴露有关,而不是其半衰期.
- 较高剂量的纳洛似乎更有效地减轻了芬太尼的再麻醉.
- 这些发现支持使用更高剂量的纳洛用于芬太尼过量服用,因为它的有效性和更低的戒断风险.
相关概念视频
Opioid Analgesics: Synthetic and Semisynthetic Opioids
892
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
892
Opioid Receptors: Overview
3.9K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
3.9K
Analgesia and Pain Management
1.5K
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
1.5K
Opioid Analgesics: Morphine and Other Natural Cogeners
818
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
818
Drug Abuse and Addiction: Pharmacological Phenomena
1.1K
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
1.1K
Desensitization and Tachyphylaxis
3.0K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
3.0K


